Want to join the conversation?
$STJ 2Q15 Q&A: Bob of BofA seeks clarification on the go-shop period. Deal could be 5-10% accretive by 2018? Dan replied, your analysis strikes me as reasonable. As you go out 2018, a lot will change. We will be making decisions with respect to standalone accretion, which is to reinvest potential accretion rather let it drop down to EPS.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.